Note: Ingredients listed on restricted chemical lists
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
50 - 100
EC/CAS
231-783-9/7727-37-9
Name of the chemical
Nitrogen N2
Concentration
≤1
General Information
Version
1.3
Revision date
2023-10-29
Product name
RI004 NFLY spray
1.2.1 Relevant identified uses
Industrial/Professional use spec
supplier name
Hranipex Ltd
Manufacturer Name
Riepe Gmbh & Co. KG GmbH
Emergency telephone
0344 892 0111, +44 20 7188 7188
Icons in SDS
Company Information
company name
Riepe Gmbh & Co. KG GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@riepe.eu, cz-hranipex@hranipex.com, uk-hranipex@hranipex.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H222, H229, H319
Hazard statements
Code
Statements
H222
Extremely flammable aerosol
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Pressurised container: May burst if heated. Extremely flammable aerosol. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07
Signal word
Danger
Hazard statements
H222 - Extremely flammable aerosol. H229 - Pressurised container: May burst if heated. H319 - Causes serious eye irritation.
Precautionary statements
P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P211 - Do not spray on an open flame or other ignition source. P251 - Do not pierce or burn, even after use. P280 - Wear protective gloves, Safety glasses, face shield. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P410+P412 - Protect from sunlight. Do not expose to temperatures exceeding 50 °C/122 °F.
Additional information
49,005001 % by mass of the contents are flammable.
PBT Substances
not yet assessed
vPvB Substances
not yet assessed The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
